Keling had met succes ons na producten op 25 Oct.2017 tegen Portugal NO.M170807 geleverd; Hun geleverde Luchtfilters hebben naar genoegen sinds installatie gewerkt. Wij zijn tevreden met hun producten.
—— SIMPOR PHARMA
Aangezien wij coopertae met hen doen, bieden zij altijd goede kwaliteit aan en houden op tijd de levering aan ons, doen wij appreicated voor hun vriendelijke steun!
—— Nasir
Dit moet verklaren dat wij u-type de tunnel van de luchtdouche, Luchtdouche en HEPA-filter, Secundaire luchtfilter, perfilter voor ons project van KeLing-Co. Ltd, de de Handels Vierkante, Medio Bouw van 3C01 Tian Feng, Nr 133, Baiyun AV, Baiyun Disctrict, Guangzhou, Guangdong, China van de Reinigingstechnologie tegen Contract Nr kochten: 2014/4119005942 in 22 Oktober, 201
—— IATEC, Argentinië
Het product kwam sneller aan dan verwacht en zij verzonden iets speciaal naast tot wat ik opdracht gaf. De personen van Nice en de snelle dienst!
—— Mohammed Saad
Ik ben online Chatten Nu
Bedrijf Nieuws
The Global Market for Modular Cleanrooms: A 2026 Forecast
Market Size & Growth Projections
2025 Baseline: The global modular cleanroom market is estimated to reach $1.8–2.1 billion by the end of 2025, driven by expanding demand in pharmaceuticals, electronics, and biotech.
2026 Forecast: Market size is projected to grow to $2.1–2.5 billion in 2026, representing a 15–20% year-over-year growth rate.
Long-Term Trajectory: Through 2030, the market is expected to maintain a CAGR of 12–15%, reaching $4.5–5.2 billion by the end of the decade. This growth is fueled by regulatory tightening, biopharma expansion, and semiconductor manufacturing investments.
Regional Breakdown
North America: Dominates the market with a 35–40% share in 2026, driven by robust biotech and semiconductor sectors. The U.S. accounts for over 80% of regional demand, supported by FDA regulations and investments in advanced manufacturing.
Asia-Pacific: The fastest-growing region, with a CAGR of 18–20% in 2026. China, India, and South Korea lead growth, driven by:
Expanding generic drug production in India
Semiconductor manufacturing hubs in China and South Korea
Rising healthcare infrastructure investments across Southeast Asia
Europe: Holds a 25–30% share, with Germany and the UK as key markets. Growth is tied to pharmaceutical R&D and medical device manufacturing, aligned with EU GMP regulations.
Key Application Segments
Pharmaceuticals & Biotech: The largest segment (40–45% of market share in 2026), driven by demand for sterile manufacturing environments for vaccines, cell therapies, and biologics.
Electronics & Semiconductors: Accounts for 25–30% of demand, fueled by miniaturization of components requiring ISO Class 5–7 cleanrooms.
Medical Devices: Grows at a 16–18% CAGR in 2026, as regulatory standards tighten for implantable devices and diagnostic equipment.
Aerospace & Defense: Emerging segment with 10–12% growth, driven by precision manufacturing of satellite components and defense electronics.